Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen

COPYRIGHTED MATERIAL, DO NOT REPRODUCE

By Mahdi A. Shkoukani, MD, Michael A. Carron, MD, Ozlem Tulunay, MD, Omer Kucuk, MD, and Ho-Sheng Lin, MD, FACS


Please sign in with your existing account or create an account to log in and print full article content.


COPYRIGHT 2017 BY VENDOME GROUP. UNAUTHORIZED REPRODUCTION OR DISTRIBUTION STRICTLY PROHIBITED